4.7 Article

Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial

期刊

CRITICAL CARE
卷 26, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s13054-021-03873-2

关键词

C-reactive protein; Corticosteroids; Coronavirus disease 2019

资金

  1. American Heart Association COVID-19 Rapid Response Grant
  2. Mayo Clinic Critical Care Independent Multidisciplinary Program (IMP) Research Grant (Institutional Departmental grant)
  3. National Center for Advancing Translational Science (NCATS) [UL1 TR002377]
  4. Office of Research and Diversity Inclusion Research Career Support and Advancement Award
  5. National Heart, Lung, and Blood Institute [K23HL151671]

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据